Publications

5808 Results

Interim report of on-study demographics and toxicity from E1505, a phase III randomized trial of adjuvant (adj) chemotherapy (chemo) with or without bevacizumab (B) for completely resected early stage non-small cell lung cancer (NSCLC)

Authors
H Wakelee;S Dahlberg;S Keller;DR Gandara;SL Graziano;AA Adjei;JH Schiller
Journal / Conference
Journal of Clinical Oncology 29:(suppl; abstr 7013)ASCO 2011 Annual Meeting, poster discussion presentation
Year
2011
Research Committee(s)
Lung
Study Number(s)
CTSU/E1505

Gene expression profiling using paraffin-embedded tissues and the nuclease protection assay in diffuse large B-cell lymphoma (DLBCL) treated with CHOP or R-CHOP: an ECOG and SWOG correlative study of E4494

Authors
JN Winter;F Hong;L Rimsza;M LeBlanc;D Variakojis;M Krajewska;T Haberman;AM Melnick;JK Wwick;JC Reed;RI Fisher;BS Kahl;RD Gascoyne
Journal / Conference
International Conference on Malignant Lymphoma, poster presentation
Year
2011
Research Committee(s)
Lymphoma
Study Number(s)
E4494

14-day triple, 5-day concomitant, and 10-day sequential therapies for helicobacter pylori infection in seven Latin American sites: a randomised trial [PMID:21777974;PMC3313469]

Authors
ER Greenberg;GL Anderson;DR Morgan;J Torres;WD Chey;LE Bravo;RL Dominguez;C Ferreccio;R Herrero;EC Lazcano-Ponce;M Meza-Montenegro;R Pena;E Salazar-Martinez;P Correa;ME Martinez;M Valdivieso;GE Goodman;J Crowley;LH Baker
Journal / Conference
Lancet 378(9790):507-514;
Year
2011
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0701

A phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status [PMID21810677; PMC3164246]

Authors
W Stadler;SP Lerner;S Groshen;JP Stein;E Tuazon;D Skinner;D Raghavan;D Esrig;G Steinberg;D Wood;L Klotz;C Hall;R Cote
Journal / Conference
Journal of Clinical Oncology 29(25):3443-3449;
Year
2011
Research Committee(s)
Genitourinary
Study Number(s)
4B951

Prognostic factor analyses of myeloma survival with intergroup trial S9321 (INT 0141): examing whether different variables govern different time segments of survival [PMID21153898;PMC3053415]

Authors
B Barlogie;V Bolejack;M Schell;J Crowley
Journal / Conference
Annals of Hematology 90(4):423-428
Year
2011
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9321

Effect of vitamin E and selenium on F2-isoprostanes, a biomarker of oxidative stress

Authors
KA Guertin;RK Grant;AR Kristal;KB Arnold;JJ Crowley;JA Hartline;PJ Goodman;CM Tangen;LM Minasian;SM Lippman;EA Klein;PA Cassano
Journal / Conference
North American Congress of Epidemiology, 3rd annual meeting (6/21-24/11 Montreal), poster presentation;
Year
2011
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000C

The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704 [PMID20934270; PMC3038247]

Authors
TN Showalter;KA Winter;AC Berger;WF Regine;RA Abrams;H Safran;JP Hoffman;AB Benson;JS Macdonald;CG Willett
Journal / Conference
International Journal of Radiation Oncology Biology Physics 81(5):1328-1335
Year
2011
Research Committee(s)
Gastrointestinal
Study Number(s)
R9704

American Society of Clinical Oncology executive summary ofthe clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer [PMID 21343561]

Authors
CH Van Posnak;S Temin;NA Janian;WE Barlow;JS Bierman;LD Bosserman;C Geoghegan;BE Hillner;RL Theriault;DS Zuckerman;JH Von Roenn
Journal / Conference
Journal of Clinical Oncology 29(9):1221-1227
Year
2011
Research Committee(s)
Breast

Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group [PMID20878269]

Authors
RD Rao;M Cobleigh;R Gray;ML Graham;L Norton;S Martino;GT Budd;JN Ingle;WC Wood
Journal / Conference
Medical Oncology 28 Suppl 1:S39-47;
Year
2011
Research Committee(s)
Breast
Study Number(s)
SWOG-9514 (EB193)

Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial[PMID21300930; PMC3083866]

Authors
PA Ganz;SR Land;CE Geyer;RS Cecchini;JP Costantino;ER Pajon;L Fehrenbacher;JA Atkins;JA Polikoff;VG Vogel;JK Erban;RB Livingston;EA Perez;EP Mamounas;N Wolmark;SM Swain
Journal / Conference
Journal of Clinical Oncology 29(9):1110-1116
Year
2011
Research Committee(s)
Breast